Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
|
US |
|
Sprott Inc
TSX:SII
|
CA |
|
Adani Power Ltd
BSE:533096
|
IN |
|
High Tide Inc
XTSX:HITI
|
CA |
|
J
|
J.Front Retailing Co Ltd
TSE:3086
|
JP |
|
Uniti Group Ltd
ASX:UWL
|
AU |
|
G
|
George Weston Ltd
F:WX5
|
CA |
|
W
|
Windfall Geotek Inc
OTC:WINKF
|
CA |
|
Absci Corp
NASDAQ:ABSI
|
US |
|
Bradespar SA
BOVESPA:BRAP4
|
BR |
|
Toyota Industries Corp
TSE:6201
|
JP |
|
Newcrest Mining Ltd
ASX:NCM
|
AU |
|
T
|
Teleperformance SE
XBER:RCF
|
FR |
|
National Bank of Canada
TSX:NA
|
CA |
|
C
|
Compal Electronics Inc
LSE:CEIR
|
TW |
|
A
|
Austal Ltd
F:LX6
|
AU |
|
I
|
Indian Oil Corporation Ltd
BSE:530965
|
IN |
|
Casella Waste Systems Inc
NASDAQ:CWST
|
US |
|
Taiheiyo Cement Corp
TSE:5233
|
JP |
|
R
|
R R Kabel Ltd
NSE:RRKABEL
|
IN |
|
Enact Holdings Inc
NASDAQ:ACT
|
US |
|
Bolsa Mexicana de Valores SAB de CV
BMV:BOLSAA
|
MX |
|
H
|
Hummingbird Resources PLC
OTC:HUMRF
|
UK |
|
Bluejay Diagnostics Inc
NASDAQ:BJDX
|
US |
Bankruptcy Probability
Arcutis Biotherapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arcutis Biotherapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
|
2.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
401.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arcutis Biotherapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arcutis Biotherapeutics Inc has total debt of 101.5m USD. This includes both short-term (0 USD) and long-term (101.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
